Search

Eric Olson

Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1693, 1673, 1623
Total Applications
1758
Issued Applications
971
Pending Applications
175
Abandoned Applications
632

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6959559 [patent_doc_number] => 20050215568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Substituted oxetanes, method of making, and method of use thereof' [patent_app_type] => utility [patent_app_number] => 10/992805 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11723 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215568.pdf [firstpage_image] =>[orig_patent_app_number] => 10992805 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/992805
Substituted oxetanes, method of making, and method of use thereof Nov 18, 2004 Issued
Array ( [id] => 7111729 [patent_doc_number] => 20050209185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 10/994030 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34199 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209185.pdf [firstpage_image] =>[orig_patent_app_number] => 10994030 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/994030
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases Nov 17, 2004 Abandoned
Array ( [id] => 7046135 [patent_doc_number] => 20050250730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 10/991634 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34198 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250730.pdf [firstpage_image] =>[orig_patent_app_number] => 10991634 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/991634
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases Nov 17, 2004 Abandoned
Array ( [id] => 7249877 [patent_doc_number] => 20050142087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Compositions containing silicone-in-water emulsions, salts, alcohols and solvents' [patent_app_type] => utility [patent_app_number] => 10/989847 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6695 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142087.pdf [firstpage_image] =>[orig_patent_app_number] => 10989847 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/989847
Compositions containing silicone-in-water emulsions, salts, alcohols and solvents Nov 11, 2004 Abandoned
Array ( [id] => 7011405 [patent_doc_number] => 20050065121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters' [patent_app_type] => utility [patent_app_number] => 10/977752 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 29453 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065121.pdf [firstpage_image] =>[orig_patent_app_number] => 10977752 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/977752
Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters Oct 28, 2004 Abandoned
Array ( [id] => 5252731 [patent_doc_number] => 20070134187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders' [patent_app_type] => utility [patent_app_number] => 10/577444 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5904 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134187.pdf [firstpage_image] =>[orig_patent_app_number] => 10577444 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/577444
Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders Oct 28, 2004 Issued
Array ( [id] => 6966092 [patent_doc_number] => 20050232989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Process for preparing oral calcium compositions' [patent_app_type] => utility [patent_app_number] => 10/973352 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5971 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232989.pdf [firstpage_image] =>[orig_patent_app_number] => 10973352 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/973352
Process for preparing oral calcium compositions Oct 26, 2004 Abandoned
Array ( [id] => 5080265 [patent_doc_number] => 20070123489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome' [patent_app_type] => utility [patent_app_number] => 10/974566 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17873 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123489.pdf [firstpage_image] =>[orig_patent_app_number] => 10974566 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/974566
Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome Oct 26, 2004 Issued
Array ( [id] => 7257687 [patent_doc_number] => 20050143573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Reduced malto-oligosaccharides' [patent_app_type] => utility [patent_app_number] => 10/963681 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5468 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143573.pdf [firstpage_image] =>[orig_patent_app_number] => 10963681 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/963681
Reduced malto-oligosaccharides Oct 12, 2004 Issued
Array ( [id] => 435923 [patent_doc_number] => 07262180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye' [patent_app_type] => utility [patent_app_number] => 10/963848 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7994 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262180.pdf [firstpage_image] =>[orig_patent_app_number] => 10963848 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/963848
Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye Oct 11, 2004 Issued
Array ( [id] => 5259749 [patent_doc_number] => 20070213381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Topical Compositions Comprising Telmesteine for Treating Dermatological Disorders' [patent_app_type] => utility [patent_app_number] => 10/575023 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4415 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213381.pdf [firstpage_image] =>[orig_patent_app_number] => 10575023 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575023
Topical Compositions Comprising Telmesteine for Treating Dermatological Disorders Oct 6, 2004 Abandoned
Array ( [id] => 7110533 [patent_doc_number] => 20050207988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Polysaccharides for pulmonary delivery of active agents' [patent_app_type] => utility [patent_app_number] => 10/957218 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26814 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20050207988.pdf [firstpage_image] =>[orig_patent_app_number] => 10957218 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/957218
Polysaccharides for pulmonary delivery of active agents Sep 30, 2004 Issued
Array ( [id] => 6939740 [patent_doc_number] => 20050113303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Use of PEX in the treatment of metabolic bone diseases' [patent_app_type] => utility [patent_app_number] => 10/952878 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13958 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113303.pdf [firstpage_image] =>[orig_patent_app_number] => 10952878 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/952878
Inhibition of PEX in the treatment of metabolic bone diseases Sep 29, 2004 Issued
Array ( [id] => 6918773 [patent_doc_number] => 20050096334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome' [patent_app_type] => utility [patent_app_number] => 10/947967 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4092 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096334.pdf [firstpage_image] =>[orig_patent_app_number] => 10947967 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/947967
Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome Sep 22, 2004 Abandoned
Array ( [id] => 7250888 [patent_doc_number] => 20050142270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Functional sweetener' [patent_app_type] => utility [patent_app_number] => 10/946613 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2464 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142270.pdf [firstpage_image] =>[orig_patent_app_number] => 10946613 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/946613
Functional sweetener Sep 21, 2004 Abandoned
Array ( [id] => 102627 [patent_doc_number] => 07723296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof' [patent_app_type] => utility [patent_app_number] => 10/943893 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 26 [patent_no_of_words] => 12761 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723296.pdf [firstpage_image] =>[orig_patent_app_number] => 10943893 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/943893
Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof Sep 19, 2004 Issued
Array ( [id] => 5688961 [patent_doc_number] => 20060287276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Compositions comprising oligosaccharides' [patent_app_type] => utility [patent_app_number] => 10/572664 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6841 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287276.pdf [firstpage_image] =>[orig_patent_app_number] => 10572664 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/572664
Compositions comprising oligosaccharides Sep 16, 2004 Issued
Array ( [id] => 4442356 [patent_doc_number] => 07928089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Mucoactive agents for treating a pulmonary disease' [patent_app_type] => utility [patent_app_number] => 10/571184 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 17150 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928089.pdf [firstpage_image] =>[orig_patent_app_number] => 10571184 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/571184
Mucoactive agents for treating a pulmonary disease Sep 14, 2004 Issued
Array ( [id] => 7034205 [patent_doc_number] => 20050032715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds' [patent_app_type] => utility [patent_app_number] => 10/942723 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3098 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032715.pdf [firstpage_image] =>[orig_patent_app_number] => 10942723 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/942723
Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds Sep 14, 2004 Abandoned
Array ( [id] => 6996680 [patent_doc_number] => 20050136458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Method for nucleic acid preparation' [patent_app_type] => utility [patent_app_number] => 10/984030 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6452 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136458.pdf [firstpage_image] =>[orig_patent_app_number] => 10984030 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/984030
Method for nucleic acid preparation Sep 13, 2004 Abandoned
Menu